Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 517


Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure.

Lin HJ, Chao CL, Chien KL, Ho YL, Lee CM, Lin YH, Wu YW, Hsu RB, Chou NK, Wang SS, Chen CY, Chen MF.

Clin Res Cardiol. 2009 Aug;98(8):487-92. doi: 10.1007/s00392-009-0025-1. Epub 2009 May 26.


The significance of serum urea and renal function in patients with heart failure.

Gotsman I, Zwas D, Planer D, Admon D, Lotan C, Keren A.

Medicine (Baltimore). 2010 Jul;89(4):197-203. doi: 10.1097/MD.0b013e3181e893ee.


Relation of blood urea nitrogen to long-term mortality in patients with heart failure.

Cauthen CA, Lipinski MJ, Abbate A, Appleton D, Nusca A, Varma A, Goudreau E, Cowley MJ, Vetrovec GW.

Am J Cardiol. 2008 Jun 1;101(11):1643-7. doi: 10.1016/j.amjcard.2008.01.047. Epub 2008 Apr 9.


Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy.

Shalaby A, El-Saed A, Voigt A, Albany C, Saba S.

Pacing Clin Electrophysiol. 2008 May;31(5):575-9. doi: 10.1111/j.1540-8159.2008.01043.x.


Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.

Circulation. 2009 Oct 20;120(16):1577-84. doi: 10.1161/CIRCULATIONAHA.109.853648. Epub 2009 Oct 5.


Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Klein L, Massie BM, Leimberger JD, O'Connor CM, Piña IL, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators.

Circ Heart Fail. 2008 May;1(1):25-33. doi: 10.1161/CIRCHEARTFAILURE.107.746933.


Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY.

N Engl J Med. 2004 Sep 23;351(13):1296-305. Erratum in: N Engl J Med. 2008;18(4):4.


Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure.

Peterson PN, Magid DJ, Lyons EE, Clarke CL, Zeng C, Fitzgerald A, Lindenfeld J, Kosiborod M, Brand D, Masoudi FA.

Am Heart J. 2010 Jan;159(1):81-9. doi: 10.1016/j.ahj.2009.10.029.


Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.

Hudson MP, O'Connor CM, Gattis WA, Tasissa G, Hasselblad V, Holleman CM, Gaulden LH, Sedor F, Ohman EM.

Am Heart J. 2004 Mar;147(3):546-52.


The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, Pfeffer MA, Yusuf S; CHARM Program Investigators.

Arch Intern Med. 2008 Aug 11;168(15):1699-704. doi: 10.1001/archinte.168.15.1699.


Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates.

Kirtane AJ, Leder DM, Waikar SS, Chertow GM, Ray KK, Pinto DS, Karmpaliotis D, Burger AJ, Murphy SA, Cannon CP, Braunwald E, Gibson CM; TIMI Study Group.

J Am Coll Cardiol. 2005 Jun 7;45(11):1781-6.


Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Yokota T, Ide T, Takeshita A, Tsutsui H; JCARE-CARD Investigators.

Circ J. 2009 Aug;73(8):1442-7. Epub 2009 Jun 12.


Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

Ueland T, Dahl CP, Kjekshus J, Hulthe J, Böhm M, Mach F, Goudev A, Lindberg M, Wikstrand J, Aukrust P, Gullestad L.

Circ Heart Fail. 2011 Mar;4(2):145-52. doi: 10.1161/CIRCHEARTFAILURE.110.957332. Epub 2011 Jan 7.


Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure.

Kearney MT, Fox KA, Lee AJ, Prescott RJ, Shah AM, Batin PD, Baig W, Lindsay S, Callahan TS, Shell WE, Eckberg DL, Zaman AG, Williams S, Neilson JM, Nolan J.

J Am Coll Cardiol. 2002 Nov 20;40(10):1801-8.


Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study.

Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O'connor C, Adams KF, Orlandi C, Gheorghiade M.

J Card Fail. 2007 Jun;13(5):360-4.


[The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].

Zoghi M, Duygu H, Güngör H, Nalbantgil S, Yilmaz GM, Tülüce K, Ozerkan F, Akilli A, Akin M.

Anadolu Kardiyol Derg. 2008 Aug;8(4):255-9. Turkish.


Prognostic impact of blood urea nitrogen changes during hospitalization in patients with acute heart failure syndrome.

Miura M, Sakata Y, Nochioka K, Takahashi J, Takada T, Miyata S, Hiramoto T, Inoue K, Tamaki K, Shiba N, Shimokawa H.

Circ J. 2013;77(5):1221-8. Epub 2013 Feb 7.


Heart failure as a cause for hospitalization in chronic dialysis patients.

Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC.

Am J Kidney Dis. 2003 Jun;41(6):1267-77.

Items per page

Supplemental Content

Write to the Help Desk